Gadolinium Safety Risks Brain Deposits

<p>Nov 22, 2017 08:11 PM</p>

<p>

see FDA bulletins: &nbsp;July 2015 and &nbsp;&nbsp;May 2017 on gad based contrast agents = GBCAs.</p>

<p>

we have ID'd NO EVIDENCE of harmful effects due to gad retention.</p>

<p>

but continuing to assess and public meetings on this in future.</p>

<p>

But... "limit GBCA use to only necessary use... &nbsp;and asses need of repeat MRI with gad.</p>

<p>

only known &nbsp;&nbsp;adverse effect is &nbsp;NSF = &nbsp;nephrogenic systemic fibrosis...</p>

<p>

painful skin disease... &nbsp;thick hard skin</p>

<p>

may be more a problem with linear GBCA. &nbsp;(more retention)</p>

<p>

Europe: EMA recomm. &nbsp;&nbsp;SUSPEND marketing of certain linear GBCAs.</p>

<p>

&nbsp;</p>

<p>

&nbsp;</p>